A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays.
The drug molecule PTC124 (Ataluren) has been described as a read-through agent, capable of suppressing premature termination codons (PTCs) and restoring functional protein production from genes disrupted by nonsense mutations. Following the discovery of PTC124 there was some controversy regarding it...
Saved in:
| Main Authors: | Stuart P McElroy, Toshifumi Nomura, Leah S Torrie, Emma Warbrick, Ulrike Gartner, Gavin Wood, W H Irwin McLean |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS Biology |
| Online Access: | https://doi.org/10.1371/journal.pbio.1001593 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of mitochondrial RNA editing sites and stop codon-lacking transcripts in angiosperms
by: Runxian Yu, et al.
Published: (2025-07-01) -
Protein Phosphatases MoPtc5, MoPtc1, and MoPtc2 Contribute to the Vegetative Growth, Stress Adaptation, and Virulence of <i>Magnaporthe oryzae</i>
by: Jules Biregeya, et al.
Published: (2025-03-01) -
The experience of using ataluren in Duchenne muscular dystrophy in Moscow: first results
by: T. N. Kekeeva, et al.
Published: (2024-01-01) -
Mediation as Problem-Solving Scene in the Light of PTC
by: Viktor Németh
Published: (2014-05-01) -
The incidence of PTC taste sensitivity in the population of Ankara
by: B Say, et al.
Published: (1966-07-01)